23 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
could hinder these agencies’ ability to hire and retain key leadership and other personnel, prevent new products and services from being developed
PRE 14A
IMPLQ
Impel Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:11pm
relations section of our website at https://investors.impelpharma.com/corporate-governance/governance-highlights.
Board Composition and Leadership … periodically consider the leadership structure of our Board of Directors and make such recommendations to the Board of Directors with respect thereto
8-K
sw3ykmlv1xw
12 Apr 23
Departure of Directors or Certain Officers
4:06pm
DEF 14A
kl7etvl
26 Apr 22
Definitive proxy
4:16pm
8-K
EX-99.1
zoj03td
14 Apr 22
Regulation FD Disclosure
8:30am
10-K
ce02o4a2bvh3ffxp
29 Mar 22
Annual report
5:09pm
8-K
EX-99.2
4wq4ezhf
18 Jan 22
Impel NeuroPharma Provides Updates on TrudhesaTM Launch
8:01am
424B4
2mo6xjm22u gtlybcfs
10 Sep 21
Prospectus supplement with pricing info
4:01pm
DRS
y3c2pi4db67
25 Aug 21
Draft registration statement
12:00am
10-Q
cnq1z44sbll
7 Jun 21
Quarterly report
7:17am
424B1
js5hxic6k6 szic
23 Apr 21
Prospectus with pricing info
4:01pm